President and CEO of Leo Pharma to resign

After more than two years leading the Danish pharmaceutical company, the board of directors and CEO Catherine Mazzacco have agreed she will step down.

Photo: Leo Pharma / PR

President and CEO of Leo Pharma Catherine Mazzacco has led the company in the development of a new capital and governance structure, and according to a press statement, the CEO and board of directors have "concluded that this would be the right time for LEO Pharma to recruit a new CEO."

"On behalf of the Board, I would like to express our sincere thanks to Catherine Mazzacco for her commendable efforts in leading the transformation of LEO Pharma towards a leadership position in the innovative space of medical dermatology. Catherine Mazzacco has been instrumental in driving the company’s ambitious growth strategy towards 2030," Chairman of the Board Jesper Brandgaard says in the press release.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs